<--- Back to Details
First PageDocument Content
Molecular genetics / Protein kinases / FOXO3 / Daf-2 / RNA interference / Daf-16 / Protein kinase B / Dauer larva / Mechanistic target of rapamycin / Insulin-like growth factor 1
Date: 2009-06-26 11:13:10
Molecular genetics
Protein kinases
FOXO3
Daf-2
RNA interference
Daf-16
Protein kinase B
Dauer larva
Mechanistic target of rapamycin
Insulin-like growth factor 1

doi:j.cell

Add to Reading List

Source URL: blackwellweb.joslin.harvard.edu

Download Document from Source Website

File Size: 1,76 MB

Share Document on Facebook

Similar Documents

Biology / Cell biology / Biochemistry / Transcription factors / Protein complexes / Proteins / Signal transduction / NRF1 / MTORC1 / NFE2L2 / Mechanistic target of rapamycin / Small Maf

Free Radical Biology and Medicine–301 Contents lists available at ScienceDirect Free Radical Biology and Medicine journal homepage: www.elsevier.com/locate/freeradbiomed

DocID: 1rrvK - View Document

Medicine / Health / Clinical medicine / Rare diseases / Angiology / Lymphangioleiomyomatosis / Benign neoplasms / Signal transduction / Tuberous sclerosis / Angiomyolipoma / Sirolimus / Mechanistic target of rapamycin

Microsoft Word - AJP Jul16 PR Yue FINAL.docx

DocID: 1qQbV - View Document

Protein kinases / Signal transduction / Biochemistry / Cancer / Biology / PKC alpha / Mitogen-activated protein kinase / Hsp27 / Mechanistic target of rapamycin / Oncogene / Hepatocellular carcinoma / Extracellular signalregulated kinases

Adaptive Medicine 3(1): 11-15, 2011 DOI: AM.2011.ABA019 11 Review

DocID: 1qLH8 - View Document

Peripheral membrane proteins / Biochemistry / Biology / Chemistry / Mechanistic target of rapamycin / Signal transduction / Neuroinflammation / Alpha-synuclein / Neurotoxin / NFAT / CA1 / MPTP

Calcineurin determines toxic versus beneficial responses to α-synuclein Gabriela Caraveoa,b, Pavan K. Aulucka,c,1, Luke Whitesella, Chee Yeun Chunga, Valeriya Barua,b, Eugene V. Mosharovd, Xiaohui Yane, Manu Ben-Johnyf,

DocID: 1qF8w - View Document

Anatomy / Medicine / Autoimmune diseases / Clinical medicine / Mucinoses / Drug discovery / Systemic scleroderma / Orphan drug / Scleroderma / Mechanistic target of rapamycin

PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading de

DocID: 1qCta - View Document